首页> 中文期刊> 《中国社区医师》 >腺嘌呤磷酸核糖转移酶缺陷患儿骨与电解质代谢的改变

腺嘌呤磷酸核糖转移酶缺陷患儿骨与电解质代谢的改变

         

摘要

目的:观察腺嘌呤磷酸核糖转移酶(APRT)缺陷患者骨与电解质代谢的改变。方法:收治APRT缺陷患儿(患病组)5例,检测其骨密度(BMD)、血清甲状旁腺激素(PTH)、血清碱性磷酸酶(ALP)、血清钙(Ca)及血清磷(P)的水平,并且与正常儿童(对照组)进行比较。结果:APRT 缺陷患儿 BMD 及血清 Ca 明显低于正常儿童(P<0.05),血清 PTH、ALP及P明显高于正常儿童(P<0.05)。结论:APRT缺陷患儿骨与电解质代谢明显紊乱,呈高代谢性骨病样改变。因此在治疗时,不仅要保护肾功能,同时应纠正电解质紊乱,调节骨转换率,纠正骨质疏松。%Objective:To observe the changes of bone and electrolyte metabolism in children with adenine phosphate transferase deficiency(APRT).Methods:5 patients with APRT(the illness groups)were selected.We detected the bone mineral density (BMD), serum parathyroid hormone(PTH),serum alkaline phosphatase(ALP),serum calcium(Ca)and serum phosphorus(P) levels,and compared with normal children(the control group).Results:The BMD and serum Ca of children with APRT deficiency were significantly lower than normal children(P<0.05);serum levels of PTH,ALP and P were significantly higher than those in normal children(P<0.05).Conclusion:Children APRT deficiency have obvious bone and electrolyte metabolism disorder.It shows a high metabolic bone disease like change.Therefore,in the treatment,we should not only protect the renal function,but also correct electrolyte disorder,regulate bone turnover rate,to correct the osteoporosis.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号